XML 62 R49.htm IDEA: XBRL DOCUMENT v3.22.4
SEGMENT INFORMATION (Tables)
12 Months Ended
Oct. 31, 2022
Revenue from External Customer [Line Items]  
Segment profitability
The profitability of each of the segments is measured after excluding items such as asset impairment charges, transformational initiatives, acquisition and integration costs, non-cash amortization of intangible assets related to business combinations, interest income, interest expense, and other items as noted in the reconciliations below.
Life Sciences and Applied MarketsDiagnostics and GenomicsAgilent CrossLabTotal
Segments
 (in millions)
Year Ended October 31, 2022:    
Total net revenue$4,007 $1,389 $1,452 $6,848 
Income from operations$1,186 $301 $370 $1,857 
Depreciation expense$59 $39 $22 $120 
Share-based compensation expense (1)
$69 $25 $26 $120 
Year Ended October 31, 2021:   
Total net revenue$3,663 $1,296 $1,360 $6,319 
Income from operations$1,017 $273 $323 $1,613 
Depreciation expense$60 $39 $23 $122 
Share-based compensation expense (1)
$60 $22 $24 $106 
Year Ended October 31, 2020:   
Total net revenue$3,115 $1,047 $1,177 $5,339 
Income from operations$792 $192 $272 $1,256 
Depreciation expense$58 $39 $22 $119 
Share-based compensation expense (1)
$46 $17 $18 $81 
(1) Share-based compensation expense in 2022, 2021 and 2020 excludes amounts not allocated to the segments related to accelerated share-based compensation expense from workforce reduction and from our acquisition of BioTek and Resolution Bioscience.
Reconciliation of segment results to total enterprise results
The following table reconciles reportable segments' income from operations to Agilent's total enterprise income before taxes:
 Years Ended October 31,
 202220212020
 (in millions)
Total reportable segments' income from operations$1,857 $1,613 $1,256 
Amortization of intangible assets related to business combinations(191)(194)(184)
Acquisition and integration costs(25)(41)(41)
Transformational initiatives(30)(37)(53)
Acceleration of share-based compensation expense related to workforce reduction— (1)(2)
Asset impairments— (2)(99)
Business exit and divestiture costs (7)(5)(2)
Change in fair value of contingent consideration25 21 — 
Special compliance costs— (1)— 
Other (1)
(11)(6)(29)
Interest Income
Interest Expense(84)(81)(78)
Other income (expense), net (2)
(39)92 66 
Income before taxes, as reported$1,504 $1,360 $842 

(1) For the year ended October 31, 2020, the other category primarily includes legal costs related to a claim we pursued against Twist Bioscience Corporation in addition to other miscellaneous adjustments.
(2) For the year ended October 31, 2022 and 2021, other income (expense), net includes net gains and losses on the fair value of equity securities. For the year ended October 31, 2020, other income (expense), net includes the settlement of a legal claim against Twist Bioscience Corporation.
Assets and capital expenditures directly managed by each segment
The following table reflects segment assets and capital expenditures under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of use assets and other assets.
Life Sciences and Applied MarketsDiagnostics and GenomicsAgilent CrossLabTotal
Segments
 (in millions)
As of and for the Year Ended October 31, 2022:    
Assets$3,955 $3,489 $869 $8,313 
Capital expenditures$77 $181 $33 $291 
As of and for the Year Ended October 31, 2021:    
Assets$3,741 $3,320 $839 $7,900 
Capital expenditures$64 $100 $24 $188 
The following table reconciles segment assets to Agilent's total assets:
 October 31,
 20222021
 (in millions)
Total reportable segments' assets$8,313 $7,900 
Cash and cash equivalents1,053 1,484 
Short-term investments— 91 
Prepaid expenses119 91 
Long-term investments195 185 
Long-term and other receivables134 126 
Deferred tax assets246 309 
Right of use assets150 178 
Other322 341 
Total assets$10,532 $10,705 

The other category primarily includes over funded pension plans which are not allocated to the segments.
Revenue and assets by geographic areas
The following table presents summarized information for net revenue by geographic region. Revenues from external customers are generally attributed to countries based upon the customers' location.

United
States
China(1)
Rest of the
World
Total
 (in millions)
Net revenue:    
Year Ended October 31, 2022$2,385 $1,499 $2,964 $6,848 
Year Ended October 31, 2021$2,159 $1,273 $2,887 $6,319 
Year Ended October 31, 2020$1,752 $1,087 $2,500 $5,339 
1.China also includes Hong Kong net revenue.


The following table presents summarized information for long-lived assets by geographic region. Long lived assets consist of property, plant, and equipment, right-of-use assets, long-term receivables and other long-term assets excluding intangible assets. The rest of the world primarily consists of Asia and the rest of Europe.
United
States
GermanyRest of the
World
Total
 (in millions)
Long-lived assets:   
October 31, 2022$1,080 $151 $492 $1,723 
October 31, 2021$912 $134 $587 $1,633